Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record.

REVISED GUIDELINES FOR HIV COUNSELING, TESTING, AND REFERRAL

&NA;·2002·Infectious Diseases in Clinical Practice

Abstract

REVISED GUIDELINES FOR HIV COUNSELING, TESTING, AND REFERRAL [CDC MMWR 2001;50 RR-19:1]: The CDC’s Division of HIV/AIDS Prevention provides this 58 page document concerning HIV counseling, testing and referral. Highlights include the following: Who should be tested? Recommendations for HIV Prevention Counseling, Testing, and Referral: Clients with increased risk and in settings where those risks are found: MSM, corrections, drug/ alcohol programs, shelters, outreach, STD and TB clinics Patients from populations with >1% HIV prevalence (hospitals with seroprevalence rates of >1%) Patients from populations with <1% HIV prevalence if: a) symptoms suggest HIV (FUO, OI without known immunosuppression); b) other diagnoses suggesting HIV (STD etc.); 3) self reported high risk, 4) patient requests test Selected populations: 1) all pregnant women; 2) persons with occupational exposure; 3) persons with known non-occupational exposure Characteristics of the test: This section provides a useful summary of various tests that are available for detecting HIV, including the routine serology, rapid test, home collection test, the saliva test and the urine test. All of these are designed to detect HIV-1 except standard serology, which detects HIV-1 and 2. All use the enzyme immunoassay (EIA) for screening and a Western blot (WB) or immunofluorescence assay (IFA) for confirmation. All are considered definitive except the urine-based test, the results of which, if positive, should be confirmed with a blood sample due to reduced specificity of the Western blot on urine. Most of these tests require 1–2 weeks for results. The exception is the rapid test, which requires 10–60 minutes. This test is often preferred when determining the need for post-exposure prophylaxis, for pregnant women who present in labor, or in settings where the return rate for results is low. The only rapid test that is currently available and FDA approved is the SUDS test, which requires an on-site laboratory testing capacity. However, this report anticipates that the FDA will approve rapid tests that “could be classified as CLIA waived to avoid the requirement for on-site laboratory testing,” which means provider-read. These tests show accuracy comparable to standard HIV serology. Details are provided in Table 2.TABLE 2: Tests for HIV DetectionInterpretation of Tests: Positive tests: False positive tests are rare except in cases of laboratory error or mislabeling; patients with positive tests and no identifiable risks should be considered for repeat testing. Negative tests: False negative results can be caused by: 1) Clinical symptoms of acute HIV infection or late AIDS; 2) Infection with HIV-2 or HIV-1 group 0 infection; 3) Recent infection. Indeterminate test results: Recommendations are to repeat testing at least one month later; tests for HIV DNA or RNA are not FDA approved for diagnostic purposes, but may be used in consultation with specialists for determining the infection status of persons with in determinant results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00019048-200201000-00010

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 215

Metadata

Authors
&NA;
Venue
Infectious Diseases in Clinical Practice
Published
2002-01
Volume
11
Issue
1
Pages
32-33
ISSN
1056-9103 (ISSN-L)
OpenAlex
W4241800744
Cited by
215
References
0
FWCI
8.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: REVISED GUIDELINES FOR HIV COUNSELING, TESTING, AND REFERRAL. https://app.cochat.ai/papers/10.1097/00019048-200201000-00010
The paper
&NA;. (2002). REVISED GUIDELINES FOR HIV COUNSELING, TESTING, AND REFERRAL. Infectious Diseases in Clinical Practice. https://doi.org/10.1097/00019048-200201000-00010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.